10-KPeriod: FY2018

COLGATE PALMOLIVE CO Annual Report, Year Ended Dec 31, 2018

Filed February 21, 2019For Securities:CL

Summary

Colgate-Palmolive Company's 2018 10-K filing highlights a company focused on its core segments: Oral, Personal, and Home Care, and Pet Nutrition. Despite facing challenging global macroeconomic conditions and increased competition, Colgate-Palmolive reported a slight increase in Net Sales for 2018, driven by volume growth and modest price increases, with organic sales remaining flat. The company's strategy emphasizes innovation, consumer engagement, and driving efficiency through its 'funding-the-growth' and Global Growth and Efficiency programs. The company operates globally, with approximately 70% of its net sales generated outside the U.S., providing some resilience against country-specific risks. However, this international presence also exposes Colgate-Palmolive to significant foreign currency fluctuations and geopolitical uncertainties. The company is actively managing costs and seeking operational efficiencies, with the Global Growth and Efficiency Program in its final year aimed at structural cost reductions and improved long-term performance.

Financial Statements
Beta

Key Highlights

  • 1Colgate-Palmolive operates in two primary segments: Oral, Personal, and Home Care (85% of net sales) and Pet Nutrition (15% of net sales).
  • 2Net sales for 2018 increased slightly by 0.5% to $15,544 million, with organic sales remaining flat, indicating steady but not accelerated growth.
  • 3The company is actively engaged in cost-saving and efficiency initiatives, including the 'funding-the-growth' initiatives and the final year of its Global Growth and Efficiency Program, aiming for projected annual pretax savings of $590-$635 million.
  • 4Significant international operations expose the company to foreign currency fluctuations, though geographic diversity helps mitigate country-specific risks.
  • 5The company repurchased approximately $1.238 billion of its common stock in 2018 and increased its quarterly dividend, demonstrating a commitment to shareholder returns.
  • 6Key risks include intense global competition, increasing dependence on key retailers, regulatory changes, supply chain disruptions, and volatility in material costs.

Frequently Asked Questions

In 2018, Colgate-Palmolive's financial performance was primarily driven by modest net sales growth, largely from volume increases and slight price adjustments. The company's 'funding-the-growth' initiatives and the final stages of its Global Growth and Efficiency Program played a crucial role in managing costs and driving operational efficiencies. However, organic sales remained flat, indicating challenges in achieving broad-based top-line growth.

Colgate-Palmolive is employing several strategies to manage costs and enhance efficiency. The 'funding-the-growth' initiatives focus on reducing expenses in areas like direct materials, indirect expenses, and distribution. The company is also in the final year of its comprehensive Global Growth and Efficiency Program, which aims to streamline operations, optimize the supply chain, and reduce structural costs, with significant projected annual savings.

The primary risks identified include intense global competition from multinational and local players, increasing reliance on key retailers who may exert greater bargaining power, potential adverse impacts from changes in retail landscape (e.g., e-commerce growth), exposure to foreign currency fluctuations due to significant international operations, volatility in raw material and commodity costs, and the potential for disruptions in global supply chains or IT systems. Regulatory and legal risks, as well as brand reputation damage, are also highlighted.

Colgate-Palmolive demonstrates its commitment to shareholder returns through consistent dividend payments and share repurchases. In 2018, the company increased its quarterly cash dividend and repurchased approximately $1.238 billion of its common stock under its authorized programs, indicating a balanced approach to capital allocation.